GlassScriptPhysician profile
Krista Joanne Hoffman
NPI 1255829156
$6,962.99
in general payments reported to CMS, 2019-2025
23 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $708 · 2022: $747 · 2023: $1,016 · 2024: $3,134 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,783 · Education: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,782.89 |
| Education | $725.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,628.22 | 2021-2025 | Tremfya, Stelara, Remicade |
| Amgen INC. | $647.47 | 2021-2025 | Otezla |
| Leo Pharma INC. | $618.34 | 2021-2025 | Adbry |
| Abbvie INC. | $553.10 | 2022-2025 | |
| Genzyme Corporation | $484.73 | 2021-2025 | |
| Ucb, INC. | $365.35 | 2023-2025 | Bimzelx |
| Lilly USA, LLC | $334.77 | 2023-2025 | Taltz, Olumiant, Zepbound |
| Incyte Corporation | $269.79 | 2021-2024 | Opzelura |
| Janssen Scientific Affairs, LLC | $250.00 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $232.76 | 2022-2024 | Dupixent, Libtayo |
| Pfizer INC. | $225.72 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $207.91 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $207.55 | 2024 | Zoryve |
| Sanofi-Aventis U.S. LLC | $183.99 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $151.66 | 2021-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $146.36 | 2021-2023 | Arazlo |
| Dermavant Sciences, INC. | $122.77 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $116.79 | 2022-2025 | Aklief, Nemluvio |
| Sun Pharmaceutical Industries INC. | $86.70 | 2022-2025 | |
| Organon LLC | $41.76 | 2024-2025 | Vtama |
| Merz North America, INC. | $41.15 | 2025 | |
| Botanix Sb INC | $30.48 | 2025 | Sofdra |
| Helsinn Therapeutics (U.S.), INC. | $15.62 | 2023 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.